Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Discovery

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2159-8290.CD-12-0421PMID 23269703PMCID PMC3625496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA 1 and BRCA 2

  2015cited by this paper
• BRCA 1 Tumor Suppression Depends on BRCT Phosphoprotein Binding , But Not Its E 3 Ligase Activity

  2014cited by this paper
• Mechanisms of BRCA 1 Tumor Suppression

  2012cited by this paper
• Mechanisms of BRCA1 tumor suppression.

  2012cited by this paper
• BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity

  2011influential reference
• Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.

  2010cited by this paper
• Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach

  2010cited by this paper
• ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks.

  2010cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

  2008cited by this paper
• Fanconi anemia and breast cancer susceptibility

  2007cited by this paper
• Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

  2007cited by this paper
• Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

  2007cited by this paper
• Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects

  2006cited by this paper
• Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom

  2006cited by this paper
• Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

  2005cited by this paper
• BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

  2005cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• A full-likelihood method for the evaluation of causality of sequence variants from family data.

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002influential reference
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001cited by this paper
• Tumorigenesis in mice carrying a truncating Brca1 mutation.

  2001cited by this paper
• Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci

  2001cited by this paper
• Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing

  2001cited by this paper
• Evidence of a founder BRCA1 mutation in Scotland

  2000cited by this paper
• The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

  1999cited by this paper
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997cited by this paper
• A human BRCA1 gene knockout

  1995cited by this paper
• Mouse models of BRCA 1 and BRCA 2 deficiency : past lessons , current understanding and future prospects

  year unknowncited by this paper

• Case Report: Biallelic BRCA1 pathogenic alterations in a Fanconi Anemia patient and clinical implications of variant location

  2025cites this paper
• Global Neurocognitive and Emotional Dysfunction in Fanconi Anemia: A Neuropsychological Case Report of a 39-Year-Old Patient

  2025cites this paper
• Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay

  2025cites this paper
• E3 ligases: a ubiquitous link between DNA repair, DNA replication and human disease

  2024cites this paper
• A practice changing paper: biallelic inactivation of BRCA2 in Fanconi anaemia

  2024cites this paper
• Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity

  2024cites this paper
• Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant

  2024cites this paper
• Biallelic Germline BRCA1 Frameshift Mutations Associated with Isolated Diminished Ovarian Reserve

  2024cites this paper
• Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management

  2024cites this paper
• Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians

  2023cites this paper
• The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations

  2023cites this paper
• Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?

  2023cites this paper
• Brca1 mouse models: functional insights and therapeutic opportunities.

  2023cites this paper
• DNA repair function scores for 2172 variants in the BRCA1 amino-terminus

  2023cites this paper
• Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer

  2023cites this paper
• Tissue specificity of DNA damage and repair.

  2023cites this paper
• DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus

  2023cites this paper
• Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood

  2022cites this paper
• Clinical case study meets population cohort: Identification of a BRCA1 pathogenic founder variant in Orcadians

  2022cites this paper
• The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.

  2022cites this paper
• Cancer in children with biallelic BRCA1 variants and Fanconi anemia‐like features: Report of a malignant brain tumor in a young child

  2022cites this paper
• Interplay between the DNA Damage Response and Immunotherapy Response in Cancer

  2022cites this paper
• Identification of BRCA2 Cis Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized Oncology

  2021cites this paper
• The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.

  2021cites this paper
• Fanconi Anaemia, Childhood Cancer and the BRCA Genes

  2021cites this paper
• Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

  2021cites this paper
• A Case Report of Germline Compound Heterozygous Mutations in the BRCA1 Gene of an Ovarian and Breast Cancer Patient

  2021cites this paper
• Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology

  2021cites this paper
• Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).

  2021cites this paper
• BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin

  2021cites this paper
• Mouse Models for Deciphering the Impact of Homologous Recombination on Tumorigenesis

  2021cites this paper
• Classification of genetic variants in hereditary cancer genes

  2021cites this paper
• Genetic Counseling for Men with Prostate Cancer.

  2021cites this paper
• Diagnosis of Fanconi Anemia: Testing and Genetic Counseling

  2021cites this paper
• Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?

  2021cites this paper
• Analysis of Rare Variant c.2395C>T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan

  2020cites this paper
• BRCA1 Mutational Complementation Induces Synthetic Viability.

  2020cites this paper
• Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

  2020cites this paper
• Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation

  2020cites this paper
• The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

  2020cites this paper
• Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

  2020cites this paper
• Harveian Oration 2019: Prediction and prevention in the genomic era.

  2020cites this paper
• Inherited bone marrow failure syndromes are a diverse group of rare disorders associated with insufficient production of blood cells and cancer predisposition

  2020cites this paper
• BRCA1/P53: Two strengths in cancer chemoprevention.

  2020cites this paper
• Functional characterization of BRCA 2 variants to improve cancer risk assessment

  2020cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021

  2020cites this paper
• BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery.

  2020cites this paper
• Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities

  2020cites this paper
• Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition

  2020cites this paper
• Biallelic variants in BRCA1 gene cause a recognisable phenotype within chromosomal instability syndromes reframed as BRCA1 deficiency

  2020cites this paper
• Brca1 mutations in the coiled-coil domain impede Rad51 loading on DNA and mouse development

  2020cites this paper
• Ablation of the Brca1–Palb2 Interaction Phenocopies Fanconi Anemia in Mice

  2020cites this paper
• Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays

  2020cites this paper
• Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer

  2019cites this paper
• Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies

  2019cites this paper
• Oxidative stress and DNA damage in the mechanism of fetal alcohol spectrum disorders

  2019cites this paper
• Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains

  2019cites this paper
• Expression and prognostic significance of Fanconi anemia group D 2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer

  2019cites this paper
• The Fanconi Anemia Pathway in Cancer.

  2019cites this paper
• Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq

  2019cites this paper
• The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability

  2019cites this paper
• RNA–DNA hybrids and the convergence with DNA repair

  2019cites this paper
• Holding All the Cards—How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability

  2019cites this paper
• An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer

  2019cites this paper
• Rapid and easy detection of the five most common founder mutations in BRCA 1 and BRCA 2 genes in the Polish population using CAPS and ACRS-PCR methods

  2019cites this paper
• Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility

  2019cites this paper
• Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes

  2019cites this paper
• Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant.

  2019cites this paper
• Next Generation Sequencing Panel for Inherited Bone Marrow Failure Syndromes

  2019cites this paper
• Impact of DNA repair and stability defects on cortical development

  2018cites this paper
• What are the molecular consequences of germline mutations in breast and ovarian cancer susceptibility genes in a Norwegian breast and ovarian cancer population

  2018cites this paper
• Accurate functional classification of thousands of BRCA1 variants with saturation genome editing

  2018cites this paper
• Hereditary predisposition to breast cancer : evaluating the role of rare copy number variant, protein-truncating and missense candidate alleles

  2018cites this paper
• Population masculine au sein des familles avec mutation germinale dans les gènes BRCA1 et BRCA2 aspects cliniques et pathologiques des cancers

  2018cites this paper
• No Evidence for the Pathogenicity of the BRCA2 c.6937 + 594T>G Deep Intronic Variant: A Case-Control Analysis

  2018cites this paper
• Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1

  2018influential citation
• Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.

  2018cites this paper
• Fanconi anaemia and cancer: an intricate relationship

  2018cites this paper
• A novel method to detect the Mexican founder mutation BRCA1 ex9-12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes

  2018cites this paper
• Recent advances in understanding hematopoiesis in Fanconi Anemia

  2018cites this paper
• A tandem duplication of BRCA1 exons 1–19 through DHX8 exon 2 in four families with hereditary breast and ovarian cancer syndrome

  2018cites this paper
• The role of PALB2 in BRCA1/2-mediated DNA repair and tumor suppression

  2017influential citation
• BRCA1 homozygous unclassified variant in a patient with non-Fanconi anemia: A case report

  2017cites this paper
• Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.

  2017cites this paper
• Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.

  2017cites this paper
• Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function.

  2017cites this paper
• BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

  2017cites this paper
• Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.

  2017influential citation
• Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response

  2017cites this paper
• BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity

  2017cites this paper
• Classification of the spliceogenic BRCA1 c.4096+3A>G variant as likely benign based on cosegregation data and identification of a healthy homozygous carrier

  2017cites this paper
• A never-ending story: the steadily growing family of the FA and FA-like genes

  2017cites this paper
• Breast cancer genetics in young women: What do we know?

  2017cites this paper
• ACCIDENTAL DUPLICATION: Beyond interstrand crosslinks repair: Contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.

  2017cites this paper
• The genomics of inherited bone marrow failure: from mechanism to the clinic

  2017cites this paper
• Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure

  2017cites this paper
• Treatment of BRCA1/2-associated breast cancer and identification of mutation carriers among breast cancer patients

  2017cites this paper
• Treatment of BRCA 1 / 2-associated breast cancer and identification of mutation carriers among breast cancer patients

  2017cites this paper
• Analysis of BRCA1 /2 Mutations and Performance of Manchester Scoring System in High Risk Iranian Breast Cancer Patients: A Pilot Study

  2017cites this paper
• Exploiting Homologous Recombination Deficiency in TNBC

  2017cites this paper